Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 6 de 6
1.
ACS Appl Mater Interfaces ; 16(15): 18734-18744, 2024 Apr 17.
Article En | MEDLINE | ID: mdl-38569072

The investigation of high-performance supercapacitors is essential for accelerating the development of energy storage devices. In this work, a 3D hierarchical nanosheet array-like nickel cobaltite/reduced graphene oxide/nickel foam composite (NiCo2O4/rGO/NF) was assembled via an aqueous coprecipitation-hydrothermal strategy assisted by citric acid. Benefiting from a NiCo layered-double-hydroxide precursor with an atomic-level lattice confinement effect of metal ions and effective hybridization with rGO, the NiCo2O4/rGO/NF composite is featured as thin NiCo2O4 nanosheets (∼113.6 nm × 11.2 nm) composed of NiCo2O4 nanoparticles (∼10.9 nm) vertically staggered on the surface of a rGO-modified NF skeleton, leading to high surface area, abundant mesoporous structure, and active site exposure. The as-obtained NiCo2O4/rGO/NF was directly used as a binder-free integrated electrode for supercapacitors, achieving an excellent specific capacitance of 2863.4 F g-1 (1503.3 C g-1) at 1 A g-1, a superior rate performance of 2335.2 F g-1 at 20 A g-1, and a stability retention of 91.7% after 5000 cycles. More impressively, a solid-state asymmetric supercapacitor assembled by the present NiCo2O4/rGO/NF integrated electrode as the positive electrode and commercial activated carbon as the negative electrode achieved a high energy density of 69.2 Wh kg-1 at a power density of 800 W kg-1, and the energy density at a peak power density of 20004 W kg-1 still remained at 48.9 Wh kg-1, also showing a good cycling stability of 87.2% retention over 10000 cycles. The present facile synthesis strategy of the as-obtained NiCo2O4/rGO/NF nanosheet array composite can be used for the design and construction of many other transition-metal oxide/graphene/NF composite materials with excellent structural stability and performance in energy storage and other related areas.

2.
Front Pediatr ; 11: 1180381, 2023.
Article En | MEDLINE | ID: mdl-37274823

Background: The p120-ctn protein, encoded by CTNND1, is involved in intercellular connections and regulates epithelial-mesenchymal transformation. CTNND1 mutations can lead to blepharocheilodontic syndrome (BCDS). Increasing evidence shows that although BCDS mainly manifests as craniofacial and oral deformities, it can also present as congenital heart disease, limb deformities, and neurodevelopmental disorders. Case description: We report a prenatal case of a major cardiac malformation at 24+3 weeks of gestation. Ultrasound examination revealed a hypoplastic left ventricular, aortic coarctation, and a ventricular septal defect. Genetic analysis of the fetal tissues showed the presence of a novel mutation in CTNND1 (NM_001085458.2: c.566_c.567insG; p.Pro190fs*15), which may lead to premature termination of protein coding, while both the parents harbored wild-type CTNND1. To date, only 15 CTNND1 mutations have been reported in 19 patients worldwide, of which approximately 31% (6/19) had a cardiac phenotype. Conclusion: To the best of our knowledge, this is the first case report of fetal complicated cardiac malformations caused by this CTNND1 mutation. Our findings provide new clinical references for prenatal diagnosis and suggest an important role for CTNND1 in early cardiac development.

3.
ACS Appl Mater Interfaces ; 14(24): 27775-27790, 2022 Jun 22.
Article En | MEDLINE | ID: mdl-35679591

Water-soluble captopril-capped atomically precise Pd nanoclusters (Pd17Capt8 NCs: 1.3 ± 0.5 nm) produced by a simple chemical reduction were supported on preprepared hybrid Co3Al-layered double hydroxide/reduced graphene oxide (Co3Al-LDH/rGO) by a pH-adjusted electrostatic adsorption strategy followed by proper calcinations, giving a series of novel catalysts x-PdNCs/CoAl(O)/rGO-T (x (Pd loading) = 0.09, 0.17, 0.43 wt % (ICP), T = 230, 250, 280, 300, 320 °C). The characterization results show that the as-obtained catalysts possess the hierarchical nanosheet array morphology. Pd NCs with a size of ∼1.3 to 1.8 nm are highly distributed at the edge sites of the CoAl(O) nanosheets. All of the x-PdNCs/CoAl(O)/rGO-T catalysts show superior catalytic efficiency for the conversion of 4-nitrophenol to 4-aminophenol, particularly 0.17-PdNCs/CoAl(O)/rGO-300 possesses the highest performance with a turnover frequency (TOF) of 30 042 h-1, which is the highest among the reported Pd-based catalysts so far. The superior activity of 0.17-PdNCs/CoAl(O)/rGO-300 can be owing to ultrafine Pd NCs with a clean surface, the strongest PdNCs-Co2+-OH(LDH)-rGO three-phase synergy, and the much improved adsorption of the substrate via π-π stacking upon nanosheet array morphology. Meanwhile, 0.17-PdNCs/CoAl(O)/rGO-300 exhibits excellent catalytic activities for various nitroarenes and anionic azo dyes as well as good reusability with the complete reduction of 4-nitrophenol (4-NP) within 90 s after 10 successive runs. The present work provides not only a simple and convenient strategy for the synthesis of clean, efficient, and environmentally friendly supported metal nanocluster catalysts but also a new idea for the efficient catalytic degradation of environmental pollutants.

4.
ACS Appl Mater Interfaces ; 14(21): 24265-24280, 2022 Jun 01.
Article En | MEDLINE | ID: mdl-35604135

A series of Co-doped ternary CuxCo3-xAl-layered double hydroxide (LDH)/rGO nanosheet array hybrids (x = 0.5, 1.0, 1.5, and 2.0) were successfully prepared using the preconditioned pH value aqueous-phase coprecipitation strategy. The CuxCo3-xAl-LDH/rGO hybrids are featured as hexagonal CuCoAl-LDH nanosheets in situ anchoring onto both sides of the rGO surface in an ab-plane vertically interlaced growth pattern. The CuxCo3-xAl-LDH/rGO hybrids show excellent activity for the complete conversion of 4-nitrophenol to 4-aminophenol, especially Cu1.5Co1.5Al-LDH/rGO with the highest kapp value of 49.2 × 10-3 s-1 and TOF of 232.8 h-1, clearly higher than most copper-containing samples in the literature and even some precious ones. Thermodynamic analysis was carried out, and the values of Ea, ΔH#, ΔS#, and ΔG# were estimated. The best activity of Cu1.5Co1.5Al-LDH/rGO can be mainly ascribed to the in situ-formed ultrafine Cu2O NPs (∼4.3 nm) along with a small amount of Cu0 species, the electron transfer effect induced by atomically dispersed Co2+ species leading to the formation of electron-rich Cu species along with the Co2+/Co3+ redox couple, the strong Cu2O-CuCoAl-LDH-rGO synergy upon the nanosheet array morphology with a high surface area and pore volume, and enhanced adsorption of reactants upon π-π stacking via an rGO layer. Meanwhile, the Cu1.5Co1.5Al-LDH/rGO exhibits an excellent universality and good cycling stability for 10 continuous runs. The Cu1.5Co1.5Al-LDH/rGO also shows superior efficiency in the catalytic reduction of 4-NP solution with a high concentration (20 mM) and displays excellent reduction performance in the fixed-bed test, implying the potential applications of the current Co-doped hierarchical ternary Cu-based LDH/rGO hybrids in the continuous treatment of practical wastewater.

5.
J Matern Fetal Neonatal Med ; 35(22): 4268-4272, 2022 Nov.
Article En | MEDLINE | ID: mdl-33213225

Clinical cases of chromosome 7 long-arm end deletion are rare. Generally, 7q terminal deletion syndrome results in complex clinical phenotypes, such as microcephaly, growth and development retardation, holoprosencephaly, and sacral hypoplasia. Herein, we report the genetic and clinical features of a fetus with multiple malformations observed by prenatal ultrasound. The results showed that there was a large fragment deletion of approximately 27.7 Mb in 7q32.3-qter. The induced fetus showed facial abnormalities of cleft lip and palate, and some organ structural abnormalities (such as diaphragmatic hernia and polycystic renal dysplasia) were observed by autopsy and pathology. To provide more reliable information for disease diagnosis and genetic counseling, we reviewed and analyzed the reported cases of isolated 7q terminal syndrome.


Abnormalities, Multiple , Cleft Lip , Cleft Palate , Abnormalities, Multiple/diagnostic imaging , Abnormalities, Multiple/genetics , Chromosome Aberrations , Chromosome Deletion , Chromosome Disorders , Chromosomes, Human, Pair 7/genetics , Cleft Palate/genetics , Female , Humans , Leukemia, Myeloid, Acute , Myelodysplastic Syndromes , Pregnancy , Prenatal Diagnosis , Ultrasonography, Prenatal
6.
Ir J Med Sci ; 189(3): 825-834, 2020 Aug.
Article En | MEDLINE | ID: mdl-31900844

AIMS: This study aimed to investigate the effect of long non-coding RNA-plasmacytoma variant translocation 1 (lnc-Pvt1) knockdown on regulating cell proliferation and apoptosis, and to explore its molecular mechanism in multiple myeloma (MM). METHODS: Lnc-Pvt1 expression was detected in MM cell lines (NCI-H929, U-266, LP-1 and RPMI-8226 cell lines) and human normal plasma cells. In U-266 cells and LP-1 cells, control shRNA and lnc-Pvt1 shRNA plasmids were transferred. Rescue experiments were further performed by transfection of lnc-Pvt1 shRNA alone and lnc-Pvt1 shRNA and miR-486 shRNA plasmids. Cells proliferation, apoptosis, RNA expression, and protein expression were determined by cell counting kit-8, annexin V-FITC-propidium iodide, quantitative polymerase chain reaction, and Western blot assays, respectively. RESULTS: Lnc-Pvt1 expression was increased in MM cell lines (NCI-H929, U-266 and LP-1 cell lines) compared with human normal plasma cells. In U-266 cells, lnc-Pvt1 shRNA suppressed cell proliferation while enhanced cell apoptosis compared with control shRNA. Also, lnc-Pvt1 shRNA increased miR-486 expression compared with control shRNA. Further rescue experiment revealed that miR-486 shRNA did not change lnc-Pvt1 level, but increased CDK4 and BCAS2 expressions in lnc-Pvt1 knockdown-treated cells. In addition, miR-486 shRNA promoted cell proliferation while inhibited cell apoptosis in lnc-Pvt1 knockdown-treated cells. These results were further validated in LP-1 cells. CONCLUSIONS: Lnc-Pvt1 knockdown inhibits cell proliferation and induces cell apoptosis through potentially regulating miR-486-mediated CDK4 and BCAS2 in MM.


Cyclin-Dependent Kinase 4/metabolism , Gene Expression Regulation, Neoplastic/genetics , Multiple Myeloma/genetics , Plasmacytoma/genetics , RNA, Long Noncoding/genetics , Apoptosis , Cell Line, Tumor , Cell Proliferation , Humans
...